Molecular Discovery Systems (MDSystems)

MDSystems is a 20% owned subsidiary of BPH Corporate Limited.

The main business of the company since its launch in 2006 is drug discovery and the validation of biomarkers for disease, therapy and diagnostics. 

MDSystems has core expertise in high content and high throughput imaging and analysis, providing services for researchers worldwide.

The MDSystems owned InCell Analyser 1000 combines high-resolution imaging and high-content analysis to provide a technology that rapidly detects and quantifies cellular properties much faster than conventional methods. 

MDSystems has developed a range of high content analysis algorithms targeted to cellular processes and designed to identify and quantitate changes to protein expression, movement and subcellular location.

Molecular Discovery Systems is available for Contract Services, for further information please email admin@mdsystems.com.au or call the BPH Corporate laboratory on +61 8 9346 7404.

Partnering | ASX releases | Published Media | Visual Media
Papers | Scientist's Profile | Grants | Current Partners